NCT07440420Not yet recruiting
Evaluation of an AR-Assisted System for Standardizing Spirometry
Evaluation of an Augmented Reality Assisted System for Standardizing Spirometry (AR-SPIRO Trial): Protocol for a Two-phase Validation and Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
Spirometry is the gold-standard tool for diagnosing Chronic Obstructive Pulmonary Disease (COPD). However, its implementation in primary care is often limited by a shortage of qualified technicians and inconsistent testing quality. This study will use Augmented Reality (AR) glasses to provide real-time interaction and guidance to participants during spirometry. It will be designed as a two-phase study to evaluate the technical validity and clinical effectiveness of AR-assisted spirometry (AR-SPIRO) system.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 710 (estimated)
- First submitted
- 20 Feb 2026
- Start date
- Mar 2026
- Primary completion date
- Jun 2026
- Lead sponsor
- China-Japan Friendship Hospital
- Diseases
- COPD
- NCT number
- NCT07440420
What you commit to
- Study type: Interventional
- Planned participants: 710
- From Mar 2026 to the primary completion date, Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Presence of absolute or relative contraindications to spirometry.
- Current pregnancy.
- Severe vision or hearing impairments that preclude the effective use of Augmented Reality (AR) glasses.
Who the study is looking for
- Phase 1
- Age ≥ 18 years.
- Able to provide written informed consent.
- Phase 2
- Age ≥ 40 years.
- Cumulative smoking history of ≥10 pack-years or history of biomass fuel exposure for ≥10 years.
- Able to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.